SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-23-007435
Filing Date
2023-05-01
Accepted
2023-05-01 12:50:09
Documents
4
Period of Report
2023-06-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20230616xdef14a.htm DEF 14A 917868
2 GRAPHIC tmb-20230616xdef14a_a003.jpg GRAPHIC 3526
3 GRAPHIC tmb-20230616xdef14a_bg001.jpg GRAPHIC 114747
4 GRAPHIC tmb-20230616xdef14a_bg002.jpg GRAPHIC 105212
  Complete submission text file 0001558370-23-007435.txt   1227103
Mailing Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603
Business Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603 (312) 253-9800
Enfusion, Inc. (Filer) CIK: 0001868912 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40949 | Film No.: 23872063
SIC: 7372 Services-Prepackaged Software